Efficacy and safety of greater occipital nerve and supraorbital nerve blocks in patients with migraine: Meta-analysis; [Eficacia y seguridad del bloqueo del nervio occipital mayor y del bloqueo del nervio supraorbitario en pacientes con migraña: Meta-análisis]

Open

Hanik Badriyah Hidayati, Dessy Rakhmawati Emril, Ayu Imamatun Nisa, Arlia Ayu Damayanti, Rahmawati Nur Azizah, Muhammad Jafar Shodiq, Shalla Tama Syaifur, Citrawati Dyah Kencono Wungu, Devi Ariani Sudibyo, Shahdevi Nandar Kurniawan

2025 Journal of Pharmacy and Pharmacognosy Research Vol. 13 Issue 1 Review Cited by 2 SDG 3SDG 17 Quartile

Abstract

Context: Migraines, which affect over 10% of the global population and cause disability, prompt the review of the greater occipital nerve (GON) and supraorbital nerve (SON) blocks to minimize systemic effects. Aims: To compare GON, GON+SON block, and SON block in migraine management. Methods: Articles from 2014 to 2022, adhering to PRISMA 2020 guidelines, underwent selection based on inclusion and exclusion criteria. Cochrane RoB 2.0 assessed article quality, Review Manager ver. 5.4.1 was used for statistical analysis. Results: The meta-analysis of 13 randomized controlled trials revealed that the GON block effect on VAS score versus the control group showed a pooled MD of -0.98 (95% CI = -2.31 to 0.36, p = 0.15). GON+SON injection had a pooled effect of -3.7 (95% CI = -0.21 to 2.08, p = 0.04) compared to the control, while SON block resulted in lower VAS scores (3.08 ± 0.3 vs. 6.71 ± 0.3). Pooled mean differences for migraine attack frequency, cumulative duration, and acute medication use were -1.82 (95% CI = -3.15 to -0.5, p = 0.007), -0.25 (95% CI = -2.84 to 2.34, p = 0.85), and -1.1 (95% CI = -2.04 to 0.16, p = 0.02), respectively. The pooled odds ratio for a 50% pain reduction was 1.62 (95% CI = 0.71 to 3.68, p = 0.25). Subgroup analysis indicated that VAS score with local anesthesia had a pooled MD of -1.68 (95% CI = -3.46 to 0.11, p = 0.07). After GON injection with 15 mg bupivacaine and 10 mg lidocaine, the VAS score significantly decreased, with mean differences of -2.2 (95% CI = -4.13 to -0.27, p = 0.03) and -4.5 (95% CI = -4.66 to -4.34, p<0.00001), respectively. Conclusions: GON and SON blocks demonstrate more effectiveness compared to GON blocks. © 2025 Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA). All rights reserved.

Affiliations

Department of Neurology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Jl. Mayjend. Prof. Dr. Moestopo No. 6-8, East Java, Surabaya, 60286, Indonesia; Department of Neurology, Faculty of Medicine, Universitas Syiah Kuala, Dr. Zainoel Abidin General Academic Hospital, Jl. Tgk. Moh. Daud Beureueh, Bandar Baru, Banda Aceh, Aceh, 24415, Indonesia; Faculty of Medicine, Universitas Airlangga, Jl. Mayjend. Prof. Dr. Moestopo No. 47, East Java, Surabaya, 60132, Indonesia; Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Jl. Mayjend. Prof. Dr. Moestopo No. 47, East Java, Surabaya, 60132, Indonesia; Department of Neurology, Faculty of Medicine, Universitas Brawijaya, Dr. Saiful Anwar General Academic Hospital, Jl. Jaksa Agung Suprapto No. 2, East Java, Malang, 65112, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock